Session Information
2009 Midyear Clinical Meeting
Click here to go to the previous page
New Drugs and New Formulations in Psychiatry: Critical Analysis in Formulary Decision Making
Track:
Educational Sessions (CE)
Program Code: 208-L04
Date: Monday, December 7, 2009
Time: 2:00 PM to 4:00 PM EST
Location:
Venetian B, Level 2
MEETING PLANNING ASSOCIATE:
Click the plus sign to see more detailed information about each speaker.
Click the plus sign to see more detailed information about each speaker.
Steven Stoner, PharmD, BCPP, Chair, Division of Pharmacy Practice and Administration, University of Missouri-Kansas City School of Pharmacy
PRESENTER(S):
Click the plus sign to see more detailed information about each speaker.
Click the plus sign to see more detailed information about each speaker.
Patrick Bryant, PharmD, FSCIP, Director, Drug Information Center; and Clinical Professor, University of Missouri-Kansas City Cynthia Mascarenas, PharmD, MS, Clinical Pharmacy Specialist, Psychiatry, South Texas Veterans Health Care System Steven Stoner, PharmD, BCPP, Chair, Division of Pharmacy Practice and Administration, University of Missouri-Kansas City School of Pharmacy
Description
Planned in cooperation with The College of Psychiatric and Neurologic Pharmacists
ACPE Activity #204-000-09-208-L04P
2.0 Contact Hours / Knowledge-based
Educational Content: Level 3
Moderator: Steven C. Stoner, PharmD, BCPP, Chair, Division of Pharmacy Practice and Administration, University of Missouri-Kansas City School of Pharmacy, Kansas City
2:00 p.m. – 2:05 p.m.
Announcements
2:05 p.m. – 2:25 p.m.
Common Scenarios in the Practice Setting Involving New Medications and New Formulations in Psychiatry
Cynthia A. Mascarenas, PharmD, MS, Clinical Pharmacy Specialist, Psychiatry, South Texas Veterans Health Care System, San Antonio; and Clinical Assistant Professor, The University of Texas College of Pharmacy, Austin
2:25 p.m. – 3:05 p.m.
Application of Evidence-Based Medicine: The Five Step Process
Patrick J. Bryant, PharmD, FSCIP, Director, Drug Information Center; and Clinical Professor, University of Missouri-Kansas City, Kansas City
3:05 p.m. – 3:45 p.m.
Making Formulary Decisions With and Without the Desired Level of Evidence
Cynthia A. Mascarenas
3:45 p.m. – 4:00 p.m.
Questions, Answers, and Discussion
Learning Objectives:
ACPE Activity #204-000-09-208-L04P
2.0 Contact Hours / Knowledge-based
Educational Content: Level 3
Moderator: Steven C. Stoner, PharmD, BCPP, Chair, Division of Pharmacy Practice and Administration, University of Missouri-Kansas City School of Pharmacy, Kansas City
2:00 p.m. – 2:05 p.m.
Announcements
2:05 p.m. – 2:25 p.m.
Common Scenarios in the Practice Setting Involving New Medications and New Formulations in Psychiatry
Cynthia A. Mascarenas, PharmD, MS, Clinical Pharmacy Specialist, Psychiatry, South Texas Veterans Health Care System, San Antonio; and Clinical Assistant Professor, The University of Texas College of Pharmacy, Austin
2:25 p.m. – 3:05 p.m.
Application of Evidence-Based Medicine: The Five Step Process
Patrick J. Bryant, PharmD, FSCIP, Director, Drug Information Center; and Clinical Professor, University of Missouri-Kansas City, Kansas City
3:05 p.m. – 3:45 p.m.
Making Formulary Decisions With and Without the Desired Level of Evidence
Cynthia A. Mascarenas
3:45 p.m. – 4:00 p.m.
Questions, Answers, and Discussion
Learning Objectives:
- Compare and contrast common reasons for medications to be added or deleted from medication formularies.
- Describe the evidence-based medicine review process and critical analysis in making a formulary decision.
- Explain concerns associated with the decision-making process of approving a medication onyo a formulary when the medication is a specific isomer of, or has a different delivery mechanism from, an existing product.
- Identify steps for formulary addition of medications in different practice settings.
This session is a part of:
Handout Online
